Reducing central line infections in pediatric and neonatal patients

Simon Li1, Edward Vincent S Faustino, Sergio G Golombek

  • 1Division of Pediatric Critical Care Medicine, New York Medical College, Maria Fareri Children's Hospital, 100 Woods Road Rm 2233, Valhalla, NY, 10595, USA, lis@wcmc.com.

Insights

Preventing central line-associated bloodstream infections (CLABSIs) in children has seen success with evidence-based bundles. Further research is needed on additional therapies to achieve zero CLABSI rates.

Area of Science:

  • Infection Control
  • Pediatric Healthcare
  • Clinical Research

Background:

  • Central line-associated bloodstream infections (CLABSIs) pose significant risks, particularly in pediatric populations.
  • While CLABSI rates have declined due to focused initiatives, research quality is hampered by sample size, regulatory pressures, and evolving definitions.
  • Accurate CLABSI definition is crucial for effective healthcare-associated infection reduction strategies.

Purpose of the Study:

  • To review the progress and challenges in preventing CLABSIs in pediatric and neonatal intensive care units.
  • To evaluate the effectiveness of basic evidence-based bundles and additional therapies in reducing CLABSI rates.
  • To identify areas for future research, particularly regarding cost-effectiveness of advanced CLABSI prevention methods.

Main Methods:

  • Review of existing literature and clinical practices related to CLABSI prevention strategies.
  • Analysis of the impact of basic bundles and additional therapies on CLABSI rates in pediatric settings.
  • Discussion of methodological challenges in CLABSI research, including sample size and definition issues.

Main Results:

  • Evidence-based bundles have significantly reduced CLABSI rates in pediatric and neonatal intensive care units.
  • Modified bundles have shown success when implemented in non-intensive care areas.
  • Additional therapies beyond basic bundles have produced mixed results, necessitating further investigation.

Conclusions:

  • Basic bundles are effective for CLABSI reduction, but achieving a 'zero CLABSI' rate may require substantial resource allocation.
  • More research is needed to determine the cost-effectiveness of advanced CLABSI prevention therapies.
  • Continued refinement of CLABSI definitions and research methodologies is essential.

Related Concept Videos

Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...